AstraZeneca
AZN
#45
Rank
NZ$490.65 B
Marketcap
NZ$158.25
Share price
0.34%
Change (1 day)
37.69%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): NZ$5.23

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$5.20. In 2024 the company made an earnings per share (EPS) of NZ$3.89 an increase over its 2023 EPS that were of NZ$3.29.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.2334.58%
2024NZ$3.8918.23%
2023NZ$3.2981.13%
2022NZ$1.81631.03%
2021NZ$0.25-88.11%
2020NZ$2.09136.89%
2019NZ$0.88-39.41%
2018NZ$1.45-28.27%
2017NZ$2.03-14.37%
2016NZ$2.3724.11%
2015NZ$1.91127.55%
2014NZ$0.84-51.96%
2013NZ$1.75-58.95%
2012NZ$4.25-32.2%
2011NZ$6.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
NZ$5.08-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.94-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.00 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.16 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
NZ$6.34 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
NZ$35.12 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.87 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.79 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.81 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.60 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland